Islet cell transplantation for the treatment of type 1 diabetes in the USA
β Scribed by Ikemoto, Tetsuya ;Noguchi, Hirofumi ;Shimoda, Masayuki ;Naziruddin, Bashoo ;Jackson, Andrew ;Tamura, Yoshiko ;Fujita, Yasutaka ;Onaca, Nicholas ;Levy, Marlon F. ;Matsumoto, Shinichi
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 211 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0944-1166
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Immune regulation is a complex process that depends on the maintenance of self tolerance while retaining robust immune responses against microbes. The emergence of Treg as a central mechanism for immune regulation has generated a new paradigm where Tregβresistant memory T cells and/or β
Transplantation of the islets of Langerhans has received considerable attention as a means of treating insulin-dependent diabetes mellitus. However, the number of islets needed and the level of plasma glucose control that results from this treatment method still needs to be defined. A pharmacokineti
Pregnancies complicated by insulin-dependent diabetes mellitus (IDDM) pose significant health risks to both the mother and her developing fetus. Congenital malformations in the offspring of diabetic mothers have an incidence which is 2-5 times that seen in the background. Euglycemia in the first tri